BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

952 related articles for article (PubMed ID: 23566914)

  • 1. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
    Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
    J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial.
    Mosterd K; Thissen MR; Nelemans P; Kelleners-Smeets NW; Janssen RL; Broekhof KG; Neumann HA; Steijlen PM; Kuijpers DI
    Br J Dermatol; 2008 Sep; 159(4):864-70. PubMed ID: 18717680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-fold illumination in topical 5-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) for superficial basal cell carcinoma (sBCC): A retrospective case series and cohort study.
    Kessels J; Hendriks J; Nelemans P; Mosterd K; Kelleners-Smeets N
    J Am Acad Dermatol; 2016 May; 74(5):899-906. PubMed ID: 26774689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
    de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Er:YAG ablative fractional laser-primed photodynamic therapy with methyl aminolevulinate as an alternative treatment option for patients with thin nodular basal cell carcinoma: 12-month follow-up results of a randomized, prospective, comparative trial.
    Choi SH; Kim KH; Song KH
    J Eur Acad Dermatol Venereol; 2016 May; 30(5):783-8. PubMed ID: 26551044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma.
    Cosgarea R; Susan M; Crisan M; Senila S
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):980-4. PubMed ID: 22738399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy with methyl 5-aminolevulinate.
    Lippert J; Smucler R; Vlk M
    Dermatol Surg; 2013 Aug; 39(8):1202-8. PubMed ID: 23725586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
    de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
    Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.
    Kuijpers DI; Thissen MR; Thissen CA; Neumann MH
    J Drugs Dermatol; 2006; 5(7):642-5. PubMed ID: 16865869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for basal cell carcinoma of the skin.
    Thomson J; Hogan S; Leonardi-Bee J; Williams HC; Bath-Hextall FJ
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003412. PubMed ID: 33202063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma.
    Rhodes LE; de Rie MA; Leifsdottir R; Yu RC; Bachmann I; Goulden V; Wong GA; Richard MA; Anstey A; Wolf P
    Arch Dermatol; 2007 Sep; 143(9):1131-6. PubMed ID: 17875873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study.
    Christensen E; Mørk C; Skogvoll E
    Br J Dermatol; 2012 Jun; 166(6):1342-8. PubMed ID: 22309486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
    Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
    Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy versus surgical excision to basal cell carcinoma: meta-analysis.
    Zou Y; Zhao Y; Yu J; Luo X; Han J; Ye Z; Li J; Lin H
    J Cosmet Dermatol; 2016 Dec; 15(4):374-382. PubMed ID: 27363535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers.
    Tarstedt M; Gillstedt M; Wennberg Larkö AM; Paoli J
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):420-3. PubMed ID: 26841041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma.
    Morton CA; Whitehurst C; McColl JH; Moore JV; MacKie RM
    Arch Dermatol; 2001 Mar; 137(3):319-24. PubMed ID: 11255332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of topical 5-aminolaevulinic acid photodynamic therapy diode laser single session for non-melanoma skin cancer.
    Souza CS; Felicio LB; Ferreira J; Kurachi C; Bentley MV; Tedesco AC; Bagnato VS
    Photodiagnosis Photodyn Ther; 2009; 6(3-4):207-13. PubMed ID: 19932453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
    Roozeboom MH; van Kleef L; Arits AH; Mosterd K; Winnepenninckx VJ; van Marion AM; Nelemans PJ; Kelleners-Smeets NW
    J Am Acad Dermatol; 2015 Jul; 73(1):93-8. PubMed ID: 25935596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial.
    Rhodes LE; de Rie M; Enström Y; Groves R; Morken T; Goulden V; Wong GA; Grob JJ; Varma S; Wolf P
    Arch Dermatol; 2004 Jan; 140(1):17-23. PubMed ID: 14732655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.